Aims: The study aimed to investigate the potential relationships between Guillain-Barré syndrome (GBS) and cerebral hemorrhage. Methods: Two patients diagnosed with hemorrhagic stroke and GBS were reported. More specifically, the sequential occurrence and the corresponding mechanisms of these 2 diseases were analyzed. Results: Two patients with cerebral hemorrhagic stroke developed progressive flaccid quadriplegia and life-threatening dyspnea in acute stage. Combined with the cerebrospinal fluid and electromyogram results, they were diagnosed as having acute GBS. It was found that GBS and cerebral nervous system (CNS) hemorrhage can occur successively, but the different sequences of occurrence had completely different pathogeneses. GBS following CNS hemorrhage was found to be related to the imbalance of systemic inflammatory responses, whereas CNS hemorrhage following GBS was due to blood vessel autonomous dysfunction and the use of immunoglobulin intravenously. Both groups of patients had only good prognoses when they were intensively observed. Conclusions: Despite being rare, GBS complicated with CNS hemorrhage deserves more attention due to its notable impact.

Scozzafava J, et al: Guillain-Barré syndrome following thoracic spinal cord trauma. Can J Anaesth 2008;55:441-446.
Rivas S, et al: Fulminant Guillain-Barré syndrome after closed head injury: a potentially reversible cause of an ominous examination. Case report. J Neurosurg 2008;108:595-600.
Yardimci N, et al: Can subdural hematoma be a trigger for Guillain-Barré syndrome? Int J Neurosci 2009;119:366-372.
Tan IL, Ng T, Vucic S: Severe Guillain-Barré syndrome following head trauma. J Clin Neurosci 2010;17:1452-1454.
Song W, et al: Guillain-Barré syndrome following sepsis after stereotactic aspiration for spontaneous pontine hemorrhage. Neurol Sci 2012;33:657-660.
Mantero V, et al: A cloudy story: Guillain-Barré syndrome concealed by a spontaneous intracerebral haemorrhage. Clin Neurophysiol 2013;124:1037-1038.
Zhang GZ, Li XG: Cerebral trauma, Campylobacter jejuni infection, and monosialotetrahexosylganglioside sodium mediated Guillain-Barré syndrome in a Chinese patient: a rare case event. J Neuropsychiatry Clin Neurosci 2014;26:E16-E17.
Samieirad S, et al: Unusual presentation of Guillain-Barré syndrome after mandibular fracture treatment: a review of the literature and a new case. J Oral Maxillofac Surg 2016;74:129.e1-e6.
Boghani Z, et al: Acute onset of Guillain-Barré syndrome after elective spinal surgery. World Neurosurg 2015;84:376-379.
Gande AR, Taylor IR, Nolan KM: Autonomic instability and hypertension resulting in subarachnoid haemorrhage in the Guillain-Barré syndrome. Intensive Care Med 1999;25:1432-1434.
Doss-Esper CE, et al: Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in Guillain-Barré syndrome. J Neuroimaging 2005;15:188-192.
Chang T, et al: Cerebral infarction 3 weeks after intravenous immunoglobulin for Miller Fisher syndrome: a case report. J Med Case Rep 2014;8:100.
Wei DY, et al: Reversible cerebral vasoconstriction in Guillain-Barré syndrome. J Clin Neurosci 2015;22:1201-1202.
Bolton CF: Neuromuscular manifestations of critical illness. Muscle Nerve 2005;32:140-163.
Balami JS, Buchan AM: Complications of intracerebral haemorrhage. Lancet Neurol 2012;11:101-118.
Velioğlu SK, Ozmenoğlu M, Boz C: Cerebral infarction following intravenous immunoglobulin therapy for Guillain-Barré syndrome. J Stroke Cerebrovasc Dis 2001;10:290-292.
Noda K, et al: Reversible cerebral vasoconstriction syndrome presenting as subarachnoid hemorrhage, reversible posterior leukoencephalopathy, and cerebral infarction. Intern Med 2011;50:1227-1233.
Ducros A: Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012;11:906-917.
Lilleker JB, et al: Prophylactic anticoagulation in Guillain-Barré syndrome: too much of a good thing? J Neurol Neurosurg Psychiatry 2016;87:795-797.
Nomura K: Treatment of Guillain-Barré syndrome. Brain Nerve 2015;67:1397-1410.
Vijayanarayana K, et al: Guillain-Barré syndrome: clinical presentation, treatment pattern and outcome. Value Health 2015;18:A659-A660.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.